시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 COVID 19 타액 스크리닝 검사 잠재력 시장 보고서(2025년)
COVID-19 Saliva Screening Test Potential Global Market Report 2025
상품코드 : 1825690
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,444,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,314,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,184,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

COVID-19 타액 스크리닝 검사 잠재력 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.9%로 성장할 전망이며, 60억 3,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 스크리닝 프로그램과의 통합, 규제 당국의 지원, 신속한 포인트 오브 케어 COVID-19 검사에 대한 수요 증가, 인구 증가, 전자상거래 상승 등에 기인할 것으로 보입니다. 예측 기간의 주요 동향으로는 헬스케어 이외 환경에서의 채용 증가, 디지털 헬스 플랫폼과의 통합, 차세대 기술의 출현, 기술의 진보, 전략적 파트너십 등을 들 수 있습니다.

향후 5년간의 성장률 8.9%라고 하는 예측은 이 시장 전회 예측으로부터 0.6%라고 하는 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 타국가 간 관세의 영향 때문입니다. 무역 장벽은 싱가포르와 네덜란드의 높은 처리량 타액 기반 중합효소 연쇄반응(PCR) 구성요소의 가격을 상승시켜 미국의 진단 혁신을 제한할 수 있습니다. 또한 상호관세와 무역 긴장 증가 및 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 그 영향이 더욱 광범위해질 것으로 보입니다.

헬스케어 지출 증가는 향후 수년간 COVID-19 타액 스크리닝 검사 시장의 확대를 촉진할 것으로 예측됩니다. 헬스케어 지출에는 처방약, 입원, 의사의 진찰, 의료기기, 공중보건 활동 등 헬스케어 관련 제품 및 서비스에 대한 모든 지출이 포함됩니다. 헬스케어 지출 증가는 저침습 수술, 고도 진단 기술, 신약의 연구개발 증가, 헬스케어 서비스의 이용 확대, 특수 약제 사용 등의 요인에 의해 초래됩니다. 헬스케어 지출 증가는 COVID-19 타액 스크리닝 검사 잠재력을 충분히 활용하는 데 필요한 자원을 제공하여 보다 효과적인 팬데믹 관리 및 공중 보건 결과를 향상시킵니다. 예를 들어, 국가 통계국에 따르면 2022년 영국의 헬스케어 지출은 약 3,548억 8,000만 달러(2,830억 파운드)에 이르렀으며, 2021년에 비해 0.7%의 미세 증가를 보였습니다. 따라서 헬스케어 지출 증가는 COVID-19 타액 스크리닝 검사 시장의 성장을 가속하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

The potential of saliva-based COVID-19 screening tests pertains to the possible benefits and capabilities they offer in comparison to conventional methods such as nasopharyngeal or oropharyngeal swab tests for detecting the SARS-CoV-2 virus, which causes COVID-19. This potential encompasses enhancements in testing accessibility, patient acceptance, cost-effectiveness, and safety, while also facilitating the adoption of new testing strategies and approaches for better management of the pandemic.

Key locations where the potential of COVID-19 saliva screening tests is prominent include travel stations, sports arenas, entertainment venues, corporate campuses, universities and colleges, factories, and similar settings. Travel stations are specifically designated areas within transportation hubs where individuals can undergo COVID-19 saliva screening tests before commencing their journeys. These tests utilize various technologies such as fluorescence-labeled antigen, rt-PCR, and CRISPR-Cas9, with testing conducted through centralized or decentralized approaches.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The COVID-19 saliva screening test potential market research report is one of a series of new reports from The Business Research Company that provides COVID-19 saliva screening test potential market statistics, including COVID-19 saliva screening test potential industry global market size, regional shares, competitors with a COVID-19 saliva screening test potential market share, detailed COVID-19 saliva screening test potential market segments, market trends, and opportunities, and any further data you may need to thrive in the COVID-19 saliva screening test potential industry. This COVID-19 saliva screening test potential market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The covid-19 saliva screening test potential market size has grown strongly in recent years. It will grow from $3.9 billion in 2024 to $4.28 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to the potential for home testing, unprecedented need for diagnostic testing, rise in public awareness, and research and development investment.

The covid-19 saliva screening test potential market size is expected to see strong growth in the next few years. It will grow to $6.03 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to integration with screening programs, regulatory support, growing demand for speedy, point-of-care COVID-19 tests, increasing population, and the rise of e-commerce. Major trends in the forecast period include increasing adoption in non-healthcare settings, integration with digital health platforms, emergence of next-generation technologies, technological advancements, and strategic partnerships.

The forecast of 8.9% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade barriers could limit U.S. diagnostic innovation by inflating prices of high-throughput saliva-based Polymerase Chain Reaction(PCR) components from Singapore and the Netherlands, resulting in slower mass testing rollouts and higher lab processing fees. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing healthcare expenditure is expected to drive the expansion of the COVID-19 saliva screening test market in the coming years. Healthcare expenditure includes all spending on healthcare-related products and services, such as prescription medications, hospital stays, doctor visits, medical equipment, and public health initiatives. The rise in healthcare expenditure is driven by factors like minimally invasive surgeries, advanced diagnostic technologies, increased research and development for new drugs, greater utilization of healthcare services, and the use of specialty medications. Higher healthcare spending provides the resources needed to fully leverage the potential of COVID-19 saliva screening tests, leading to more effective pandemic management and improved public health outcomes. For example, in 2022, according to the Office for National Statistics, the UK's healthcare expenditure reached around $354.88 billion (£283 billion), marking a slight increase of 0.7% compared to 2021. Therefore, the increase in healthcare expenditure is fueling the growth of the COVID-19 saliva screening test market.

Key players in the COVID-19 saliva screening test market are focusing on developing innovative technologies, such as data-sharing platforms, to improve real-time communication and collaboration among healthcare providers, laboratories, and public health authorities. This helps enhance the efficiency and accuracy of testing, tracking, and response efforts during the pandemic. Data-sharing platforms are digital systems that enable secure data exchange between various stakeholders, including healthcare providers, researchers, and organizations. They promote collaboration and facilitate access to information, thereby improving decision-making, efficiency, and outcomes across sectors. For example, in May 2024, Mount Sinai Health System, a US-based healthcare network, launched the Center for Healthcare Readiness. The Center is focused on enhancing strategies for public health emergency response, ensuring that healthcare systems can effectively manage large-scale crises, such as pandemics or natural disasters. It aims to strengthen the capacity of the Mount Sinai Health System and work with local, regional, and federal partners to develop comprehensive preparedness plans.

In July 2024, Hologic, Inc., a US-based health technology company, acquired Endomagnetics Ltd. for an undisclosed amount. Through this acquisition, Hologic, Inc. aims to broaden its portfolio of innovative healthcare solutions and expand its presence in the women's health market. Endomagnetics Ltd. is a UK-based medical technology company that develops devices designed to detect cancerous lymph nodes during surgery.

Major companies operating in the COVID-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene, FLuroTech Ltd.

North America was the largest region in the COVID-19 saliva screening test potential market in 2024. The regions covered in the COVID-19 saliva screening test potential market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the COVID-19 saliva screening test potential market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The COVID-19 saliva screening test potential market consist revenues earned by entities by providing services such as sample collection services, laboratory testing services, diagnostic reporting services, and screening and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The COVID-19 saliva screening test potential market also consists of sales of saliva collection kits, rapid saliva testing kits, laboratory testing supplies, and automated sample processing systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

COVID-19 Saliva Screening Test Potential Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on covid-19 saliva screening test potential market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for covid-19 saliva screening test potential ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The covid-19 saliva screening test potential market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. COVID-19 Saliva Screening Test Potential market Characteristics

3. COVID-19 Saliva Screening Test Potential market Trends And Strategies

4. COVID-19 Saliva Screening Test Potential market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global COVID-19 Saliva Screening Test Potential Growth Analysis And Strategic Analysis Framework

6. COVID-19 Saliva Screening Test Potential market Segmentation

7. COVID-19 Saliva Screening Test Potential market Regional And Country Analysis

8. Asia-Pacific COVID-19 Saliva Screening Test Potential market

9. China COVID-19 Saliva Screening Test Potential market

10. India COVID-19 Saliva Screening Test Potential market

11. Japan COVID-19 Saliva Screening Test Potential market

12. Australia COVID-19 Saliva Screening Test Potential market

13. Indonesia COVID-19 Saliva Screening Test Potential market

14. South Korea COVID-19 Saliva Screening Test Potential market

15. Western Europe COVID-19 Saliva Screening Test Potential market

16. UK COVID-19 Saliva Screening Test Potential market

17. Germany COVID-19 Saliva Screening Test Potential market

18. France COVID-19 Saliva Screening Test Potential market

19. Italy COVID-19 Saliva Screening Test Potential market

20. Spain COVID-19 Saliva Screening Test Potential market

21. Eastern Europe COVID-19 Saliva Screening Test Potential market

22. Russia COVID-19 Saliva Screening Test Potential market

23. North America COVID-19 Saliva Screening Test Potential market

24. USA COVID-19 Saliva Screening Test Potential market

25. Canada COVID-19 Saliva Screening Test Potential market

26. South America COVID-19 Saliva Screening Test Potential market

27. Brazil COVID-19 Saliva Screening Test Potential market

28. Middle East COVID-19 Saliva Screening Test Potential market

29. Africa COVID-19 Saliva Screening Test Potential market

30. COVID-19 Saliva Screening Test Potential market Competitive Landscape And Company Profiles

31. COVID-19 Saliva Screening Test Potential market Other Major And Innovative Companies

32. Global COVID-19 Saliva Screening Test Potential market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The COVID-19 Saliva Screening Test Potential market

34. Recent Developments In The COVID-19 Saliva Screening Test Potential market

35. COVID-19 Saliva Screening Test Potential market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기